» Articles » PMID: 31256940

Clinical Characteristics of Bacteremia Caused by Hypermucoviscous Klebsiella Pneumoniae at a Tertiary Hospital

Abstract

This study aimed to assess the predictive factors of bacteremia due to hypermucoviscous Klebsiella pneumoniae (hvKP), as well as the mortality. The medical records of 114 patients with K. pneumoniae bacteremia who were divided into the hvKP (n = 24) and non-hvKP (n = 90) groups and were retrospectively reviewed. The male-to-female ratio, age, and underlying disease did not differ between the 2 groups. Mortality was higher among patients in the hvKP bacteremia group than in the non-hvKP bacteremia group (29.2% vs 6.7%). Multivariate analysis showed that the independent predictors associated with hvKP bacteremia were abscess (P = 0.01) and no antibiotic exposure (P = 0.02); thus, early assessment of these conditions is important. For patients with a history of abscess and no antibiotic exposure, it is necessary to administer treatment while keeping the risk of hvKP in mind.

Citing Articles

Antimicrobial resistance in hypermucoviscous and non-hypermucoviscous : a systematic review and meta-analysis.

Namikawa H, Oinuma K, Kaneko Y, Kakeya H, Shuto T Emerg Microbes Infect. 2024; 14(1):2438657.

PMID: 39629681 PMC: 11650459. DOI: 10.1080/22221751.2024.2438657.


Severe co-infection caused by difficult-to-diagnose hypermucoviscous Klebsiella pneumoniae K1-ST82 in a patient with COVID-19: a case report.

Itoga M, Hayashi W, Kayama S, Yu L, Sugawara Y, Kimura M BMC Infect Dis. 2024; 24(1):1215.

PMID: 39468457 PMC: 11520518. DOI: 10.1186/s12879-024-10092-x.


Prognostic models for estimating severity of disease and predicting 30-day mortality of Hypervirulent Klebsiella pneumoniae infections: a bicentric retrospective study.

Huang J, Chen Y, Li M, Xie S, Tong H, Guo Z BMC Infect Dis. 2023; 23(1):554.

PMID: 37626308 PMC: 10464203. DOI: 10.1186/s12879-023-08528-x.


Clinical characteristics and manifestations in patients with hypermucoviscous Klebsiella pneumoniae bacteremia from extra-hepatobiliary tract infection.

Kim S, Jeon C, Kim H, Wi Y Infection. 2022; 51(3):689-696.

PMID: 36271220 DOI: 10.1007/s15010-022-01940-6.


Successful treatment of hypervirulent bacteremia with combination carbapenem and rifampicin.

Lin Y, Cao X, Mo Y, Xie C, Zhang Y, Li N IDCases. 2021; 26:e01276.

PMID: 34522614 PMC: 8426520. DOI: 10.1016/j.idcr.2021.e01276.